The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples